The biopharmaceutical company Moderna announced Thursday that it has signed a purchase contract for land in the Laval biotechnology park in order to establish its factory there, which should have a production capacity of 100 million doses of vaccines per year.
• Read also: EU reserves 15 million doses of modified Moderna vaccine
The location of the plant will be “ideal”, explains Moderna: it is the Cité de la Biotech, a developing industrial park located in the Chomedey sector which brings together major biopharmaceutical companies and research institutes. employing several thousand people.
The land was ceded by the National Institute for Scientific Research (INRS), which runs a research center in the City, of which it is a stakeholder.
“This site offers tremendous synergy opportunities for Moderna through its proximity to a reputable research institution and aligns with the requirements of the project and its importance to all Quebecers and Canadians,” Moderna said in a statement Thursday.
For the mayor of Laval, Stéphane Boyer, “it is certain that the addition of a major player like Moderna to our project is a real privilege. We welcome them today with enthusiasm and will follow this file with great attention,” he said in a written statement.
INRS said it was “happy” to be able to cede land that corresponds to the needs of the future biomanufacturing plant, which will specialize in the production of messenger RNA vaccines, a technology that first spread with the vaccines once morest COVID-19.
“There is no doubt that welcoming a partner of this magnitude will contribute to the influence of the Laval technology park in Quebec and Canada and will energize the ecosystem of life sciences and health technologies”, indicated the research institution in an email.
Construction of this biofabrication plant is expected to begin in 2022 and the plant is expected to be operational by the end of 2024, subject to planning and regulatory approvals, it was said.
The INRS might not reveal the exact address of the future factory since the due diligence is still not completed, it is underlined.
Health Minister Christian Dubé said on Twitter that “Moderna’s arrival in Quebec is a sign of health innovation. This is major, and we are very proud of it.”
